Please use this identifier to cite or link to this item:
Title: Unraveling the role of fibroblasts, FGF5 and FGFR2 in HER2-targeted therapies resistance and tumor progression
Author: Bragado, Paloma
Fernández-Nogueira, Patricia
Carbó Carbó, Neus
Gascón, Pere
Keywords: Fibroblasts
Issue Date: 8-Dec-2020
Publisher: Impact Journals
Abstract: The majority of women with HER2-positive breast cancer will initially respond to trastuzumab and/or other HER2-targeted therapies such as pertuzumab, lapatinib, neratinib and trastuzumab emtansine (T-DM1). However [...].
Note: Reproducció del document publicat a:
It is part of: Oncotarget, 2020, vol. 11, num. 49, p. 4541-4543
Related resource:
ISSN: 1949-2553
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Files in This Item:
File Description SizeFormat 
710528.pdf1.13 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons